Bile Acids: Key Players in Inflammatory Bowel Diseases? - Archive ouverte HAL Access content directly
Journal Articles (Review Article) Cells Year : 2022

Bile Acids: Key Players in Inflammatory Bowel Diseases?

(1) , (1) , (1) , (1) , (1) , (2) , (3) , (4) , (1) , (5) , (1)
1
2
3
4
5

Abstract

Inflammatory bowel diseases (IBDs) have emerged as a public health problem worldwide with a limited number of efficient therapeutic options despite advances in medical therapy. Although changes in the gut microbiota composition are recognized as key drivers of dysregulated intestinal immunity, alterations in bile acids (BAs) have been shown to influence gut homeostasis and contribute to the pathogenesis of the disease. In this review, we explore the interactions involving BAs and gut microbiota in IBDs, and discuss how the gut microbiota–BA–host axis may influence digestive inflammation.
Fichier principal
Vignette du fichier
2022_Kriaa_MDPI Cells.pdf (898.1 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Licence : CC BY - Attribution

Dates and versions

hal-03812120 , version 1 (12-10-2022)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Aicha Kriaa, Vincent Mariaule, Amin Jablaoui, Soufien Rhimi, Hela Mkaouar, et al.. Bile Acids: Key Players in Inflammatory Bowel Diseases?. Cells, 2022, 11 (5), pp.1-10. ⟨10.3390/cells11050901⟩. ⟨hal-03812120⟩
30 View
16 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More